{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T10:15:28Z","timestamp":1777889728298,"version":"3.51.4"},"reference-count":116,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T00:00:00Z","timestamp":1768176000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T00:00:00Z","timestamp":1768176000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Osteoporos"],"DOI":"10.1007\/s11657-025-01639-9","type":"journal-article","created":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T11:23:48Z","timestamp":1768217028000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The contested association between MASLD and osteoporosis: a narrative review of heterogeneous evidence and modifying factors"],"prefix":"10.1007","volume":"21","author":[{"given":"Ya-Jun","family":"Xiao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan-Ling","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Zhou","family":"Mao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Di","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan-Qun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Yan Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Ling","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chang-Feng","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cun-Liang","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,12]]},"reference":[{"key":"1639_CR1","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1016\/j.jhep.2023.06.003","volume":"79","author":"ME Rinella","year":"2023","unstructured":"Rinella ME, Lazarus JV, Ratziu V et al (2023) A multisociety Delphi consensus statement on new fatty liver disease nomenclature. J Hepatol 79:1542\u201356","journal-title":"J Hepatol"},{"key":"1639_CR2","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/S2468-1253(22)00165-0","volume":"7","author":"K Riazi","year":"2022","unstructured":"Riazi K, Azhari H, Charette JH et al (2022) The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis. The Lancet Gastroenterology & Hepatology 7:851\u2013861","journal-title":"The Lancet Gastroenterology & Hepatology"},{"issue":"2","key":"1639_CR3","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.jhep.2023.03.017","volume":"79","author":"H Devarbhavi","year":"2023","unstructured":"Devarbhavi H, Asrani SK, Arab JP et al (2023) Global burden of liver disease: 2023 update. J Hepatol 79(2):516\u2013537","journal-title":"J Hepatol"},{"issue":"1","key":"1639_CR4","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.cld.2017.08.010","volume":"22","author":"D Kim","year":"2018","unstructured":"Kim D, Touros A, Kim WR (2018) Nonalcoholic fatty liver disease and metabolic syndrome. Clin Liver Dis 22(1):133\u2013140","journal-title":"Clin Liver Dis"},{"issue":"1","key":"1639_CR5","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s12902-022-00980-1","volume":"22","author":"S Pouwels","year":"2022","unstructured":"Sharma N, Sircar A, Anders HJ et al (2018) Crosstalk between kidney and liver in non-alcoholic fatty liver disease: mechanisms and therapeutic approaches. Arch Physiol Biochem 128(4):1024-1038","journal-title":"BMC Endocr Disord"},{"issue":"2","key":"1639_CR6","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s11901-016-0295-9","volume":"15","author":"LB VanWagner","year":"2016","unstructured":"VanWagner LB, Rinella ME (2016) Extrahepatic manifestations of nonalcoholic fatty liver disease. Curr Hepatol Rep 15(2):75\u201385","journal-title":"Curr Hepatol Rep"},{"issue":"7","key":"1639_CR7","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1016\/S2468-1253(21)00020-0","volume":"6","author":"G Targher","year":"2021","unstructured":"Targher G, Tilg H, Byrne CD (2021) Non-alcoholic fatty liver disease: a multisystem disease requiring a multidisciplinary and holistic approach. Lancet Gastroenterol Hepatol 6(7):578\u2013588","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"2 Suppl","key":"1639_CR8","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1016\/j.ajog.2005.08.047","volume":"194","author":"NE Lane","year":"2006","unstructured":"Lane NE (2006) Epidemiology, etiology, and diagnosis of osteoporosis. Am J Obstet Gynecol 194(2 Suppl):S3\u2013S11","journal-title":"Am J Obstet Gynecol"},{"key":"1639_CR9","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.maturitas.2021.02.007","volume":"147","author":"SA Polyzos","year":"2021","unstructured":"Polyzos SA, Anastasilakis AD, Efstathiadou ZA et al (2021) Postmenopausal osteoporosis coexisting with other metabolic diseases: treatment considerations. Maturitas 147:19\u201325","journal-title":"Maturitas"},{"issue":"2","key":"1639_CR10","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s12020-012-9639-6","volume":"42","author":"SS Moon","year":"2012","unstructured":"Moon SS, Lee YS, Kim SW (2012) Association of nonalcoholic fatty liver disease with low bone mass in postmenopausal women. Endocrine 42(2):423\u2013429","journal-title":"Endocrine"},{"key":"1639_CR11","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/396545","volume":"2013","author":"R Cui","year":"2013","unstructured":"Cui R, Sheng H, Rui XF et al (2013) Low bone mineral density in Chinese adults with nonalcoholic fatty liver disease. Int J Endocrinol 2013:396545","journal-title":"Int J Endocrinol"},{"issue":"3","key":"1639_CR12","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1097\/MEG.0000000000000535","volume":"28","author":"HJ Yang","year":"2016","unstructured":"Yang HJ, Shim SG, Ma BO, Kwak JY (2016) Association of nonalcoholic fatty liver disease with bone mineral density and serum osteocalcin levels in Korean men. Eur J Gastroenterol Hepatol 28(3):338\u2013344","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"1639_CR13","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s12967-016-0766-3","volume":"14","author":"MF Xia","year":"2016","unstructured":"Xia MF, Lin HD, Yan HM et al (2016) The association of liver fat content and serum alanine aminotransferase with bone mineral density in middle-aged and elderly Chinese men and postmenopausal women. J Transl Med 14:11","journal-title":"J Transl Med"},{"issue":"7","key":"1639_CR14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0182202","volume":"12","author":"G Kim","year":"2017","unstructured":"Kim G, Kim KJ, Rhee Y, Lim SK (2017) Significant liver fibrosis assessed using liver transient elastography is independently associated with low bone mineral density in patients with non-alcoholic fatty liver disease. PLoS One 12(7):e0182202","journal-title":"PLoS One"},{"key":"1639_CR15","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/2314769","volume":"2018","author":"DZ Chen","year":"2018","unstructured":"Chen DZ, Xu QM, Wu XX et al (2018) The combined effect of nonalcoholic fatty liver disease and metabolic syndrome on osteoporosis in postmenopausal females in Eastern China. Int J Endocrinol 2018:2314769","journal-title":"Int J Endocrinol"},{"issue":"42","key":"1639_CR16","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000012835","volume":"97","author":"HJ Chen","year":"2018","unstructured":"Chen HJ, Yang HY, Hsueh KC et al (2018) Increased risk of osteoporosis in patients with nonalcoholic fatty liver disease: a population-based retrospective cohort study. Medicine 97(42):e12835","journal-title":"Medicine"},{"issue":"5","key":"1639_CR17","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1080\/13697137.2018.1481380","volume":"21","author":"DY Lee","year":"2018","unstructured":"Lee DY, Park JK, Hur KY, Um SH (2018) Association between nonalcoholic fatty liver disease and bone mineral density in postmenopausal women. Climacteric 21(5):498\u2013501","journal-title":"Climacteric"},{"issue":"1","key":"1639_CR18","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s00198-017-4257-z","volume":"29","author":"SH Ahn","year":"2018","unstructured":"Ahn SH, Seo DH, Kim SH et al (2018) The relationship between fatty liver index and bone mineral density in Koreans: KNHANES 2010\u20132011. Osteoporos Int 29(1):181\u2013190","journal-title":"Osteoporos Int"},{"issue":"2","key":"1639_CR19","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1530\/EJE-19-0699","volume":"182","author":"Z Shen","year":"2020","unstructured":"Shen Z, Cen L, Chen X et al (2020) Increased risk of low bone mineral density in patients with non-alcoholic fatty liver disease: a cohort study. Eur J Endocrinol 182(2):157\u2013164","journal-title":"Eur J Endocrinol"},{"key":"1639_CR20","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.825448","volume":"12","author":"T Zhai","year":"2022","unstructured":"Zhai T, Chen Q, Xu J, Jia X, Xia P (2022) Prevalence and trends in low bone density, osteopenia and osteoporosis in U.S. adults with non-alcoholic fatty liver disease, 2005-2014. Front Endocrinol (Lausanne) 12:825448","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1639_CR21","doi-asserted-by":"crossref","unstructured":"Loosen SH, Roderburg C, Demir M, et al (2022) Non-alcoholic fatty liver disease (NAFLD) is associated with an increased incidence of osteoporosis and bone fractures. Die nichtalkoholische Fettlebererkrankung (NAFLD) ist mit einer erh\u00f6hten Inzidenz von Osteoporose und Knochenfrakturen verbunden. Z Gastroenterol 60(8):1221\u20131227","DOI":"10.1055\/a-1482-9236"},{"issue":"2","key":"1639_CR22","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1007\/s12072-022-10461-1","volume":"17","author":"I Barchetta","year":"2023","unstructured":"Barchetta I, Lubrano C, Cimini FA et al (2023) Liver fibrosis is associated with impaired bone mineralization and microstructure in obese individuals with non-alcoholic fatty liver disease. Hepatol Int 17(2):357\u2013366","journal-title":"Hepatol Int"},{"issue":"5","key":"1639_CR23","volume":"16","author":"M Sukumar","year":"2024","unstructured":"Sukumar M, Vikram NK, Ranjan P et al (2024) Linking non-alcoholic fatty liver disease severity with metabolic syndrome features: an integrative study on clinical and radiological fronts. Cureus 16(5):e59788","journal-title":"Cureus"},{"issue":"11","key":"1639_CR24","doi-asserted-by":"publisher","first-page":"627","DOI":"10.4254\/wjh.v5.i11.627","volume":"5","author":"M Kaya","year":"2013","unstructured":"Kaya M, I\u015f\u0131k D, Be\u015fta\u015f R et al (2013) Increased bone mineral density in patients with non-alcoholic steatohepatitis. World J Hepatol 5(11):627\u2013634","journal-title":"World J Hepatol"},{"issue":"5","key":"1639_CR25","doi-asserted-by":"publisher","first-page":"342","DOI":"10.3961\/jpmph.20.089","volume":"53","author":"J Sung","year":"2020","unstructured":"Sung J, Ryu S, Song YM, Cheong HK (2020) Relationship between non-alcoholic fatty liver disease and decreased bone mineral density: a retrospective cohort study in Korea. J Prev Med Public Health 53(5):342\u2013352","journal-title":"J Prev Med Public Health"},{"key":"1639_CR26","doi-asserted-by":"publisher","DOI":"10.1155\/cjgh\/6969761","volume":"2025","author":"T Wu","year":"2025","unstructured":"Wu T, Li L, Mei Y et al (2025) Increased BMD in SLD patients without advanced hepatic fibrosis: evidence from the NHANES 2017-2020 database. Can J Gastroenterol Hepatol 2025:6969761","journal-title":"Can J Gastroenterol Hepatol"},{"issue":"4","key":"1639_CR27","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1007\/s00198-023-06687-w","volume":"34","author":"J Liu","year":"2023","unstructured":"Liu J, Tang Y, Feng Z et al (2023) Metabolic associated fatty liver disease and bone mineral density: a cross-sectional study of the National Health and Nutrition Examination Survey 2017\u20132018. Osteoporos Int 34(4):713\u2013724","journal-title":"Osteoporos Int"},{"issue":"3","key":"1639_CR28","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1002\/oby.23100","volume":"29","author":"BT Li","year":"2021","unstructured":"Li BT, Simon TG, Wang N et al (2021) Association between liver fat and bone density is confounded by general and visceral adiposity in a community-based cohort. Obesity 29(3):595\u2013600","journal-title":"Obesity"},{"issue":"15\u201316","key":"1639_CR29","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1007\/s00508-012-0211-4","volume":"124","author":"T Purnak","year":"2012","unstructured":"Purnak T, Beyazit Y, Ozaslan E, Efe C, Hayretci M (2012) The evaluation of bone mineral density in patients with nonalcoholic fatty liver disease. Wien Klin Wochenschr 124(15\u201316):526\u2013531","journal-title":"Wien Klin Wochenschr"},{"issue":"8","key":"1639_CR30","doi-asserted-by":"publisher","first-page":"e2856","DOI":"10.1210\/clinem\/dgab262","volume":"106","author":"S Ciardullo","year":"2021","unstructured":"Ciardullo S, Muraca E, Zerbini F, Manzoni G, Perseghin G (2021) NAFLD and liver fibrosis are not associated with reduced femoral bone mineral density in the general US population. J Clin Endocrinol Metab 106(8):e2856\u2013e2865","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"1639_CR31","doi-asserted-by":"publisher","DOI":"10.1002\/jbm4.10714","volume":"7","author":"SG Hansen","year":"2023","unstructured":"Hansen SG, Wernberg CW, Gr\u00f8nkj\u00e6r LL et al (2023) Are nonalcoholic fatty liver disease and bone mineral density associated? - A cross-sectional study using liver biopsy and dual-energy x-ray absorptiometry. JBMR Plus 7(3):e10714","journal-title":"JBMR Plus"},{"issue":"11","key":"1639_CR32","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1007\/s40618-016-0528-3","volume":"39","author":"SH Lee","year":"2016","unstructured":"Lee SH, Yun JM, Kim SH et al (2016) Association between bone mineral density and nonalcoholic fatty liver disease in Korean adults. J Endocrinol Invest 39(11):1329\u20131336","journal-title":"J Endocrinol Invest"},{"issue":"6","key":"1639_CR33","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0197900","volume":"13","author":"T Umehara","year":"2018","unstructured":"Umehara T (2018) Nonalcoholic fatty liver disease with elevated alanine aminotransferase levels is negatively associated with bone mineral density: cross-sectional study in U.S. adults. PLoS One 13(6):e0197900","journal-title":"PLoS One"},{"issue":"6","key":"1639_CR34","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1007\/s12072-021-10254-y","volume":"15","author":"JW Yoon","year":"2021","unstructured":"Yoon JW, Kim MJ, Chung GE et al (2021) Hepatic fibrosis is associated with an increased rate of decline in bone mineral density in men with nonalcoholic fatty liver disease. Hepatol Int 15(6):1347\u20131355","journal-title":"Hepatol Int"},{"key":"1639_CR35","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.857110","volume":"13","author":"R Xie","year":"2022","unstructured":"Xie R, Liu M (2022) Relationship between non-alcoholic fatty liver disease and degree of hepatic steatosis and bone mineral density. Front Endocrinol (Lausanne) 13:857110","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"2","key":"1639_CR36","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1007\/s12020-024-03934-w","volume":"86","author":"A Goyal","year":"2024","unstructured":"Goyal A, Kubihal S, Gupta Y et al (2024) Bone mass, microarchitecture and turnover among young Indian women with non-alcoholic fatty liver disease. Endocrine 86(2):790\u2013799","journal-title":"Endocrine"},{"issue":"6","key":"1639_CR37","doi-asserted-by":"publisher","first-page":"2033","DOI":"10.1210\/jc.2011-3010","volume":"97","author":"M Li","year":"2012","unstructured":"Li M, Xu Y, Xu M et al (2012) Association between nonalcoholic fatty liver disease (NAFLD) and osteoporotic fracture in middle-aged and elderly Chinese. J Clin Endocrinol Metab 97(6):2033\u20132038","journal-title":"J Clin Endocrinol Metab"},{"key":"1639_CR38","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2018.00408","volume":"9","author":"Y Wang","year":"2018","unstructured":"Wang Y, Wen G, Zhou R et al (2018) Association of nonalcoholic fatty liver disease with osteoporotic fractures: a cross-sectional retrospective study of Chinese individuals. Front Endocrinol (Lausanne) 9:408","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"3","key":"1639_CR39","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1111\/joim.13497","volume":"292","author":"A Wester","year":"2022","unstructured":"Wester A, Hagstr\u00f6m H (2022) Risk of fractures and subsequent mortality in non-alcoholic fatty liver disease: a nationwide population-based cohort study. J Intern Med 292(3):492\u2013500","journal-title":"J Intern Med"},{"issue":"6","key":"1639_CR40","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1016\/j.clnu.2024.04.034","volume":"43","author":"S Yokoyama","year":"2024","unstructured":"Yokoyama S, Honda T, Ishizu Y et al (2024) Risk factors for decreased bone mineral density in patients with metabolic dysfunction-associated steatotic liver disease: a cross-sectional study at a health examination center. Clin Nutr 43(6):1425\u20131432","journal-title":"Clin Nutr"},{"issue":"8","key":"1639_CR41","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1002\/jbmr.4862","volume":"38","author":"YH Su","year":"2023","unstructured":"Su YH, Chien KL, Yang SH et al (2023) Nonalcoholic fatty liver disease is associated with decreased bone mineral density in adults: a systematic review and meta-analysis. J Bone Miner Res 38(8):1092\u20131103","journal-title":"J Bone Miner Res"},{"issue":"2","key":"1639_CR42","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1042\/cs1020151","volume":"102","author":"C Livingstone","year":"2002","unstructured":"Livingstone C, Collison M (2002) Sex steroids and insulin resistance. Clin Sci 102(2):151\u2013166","journal-title":"Clin Sci"},{"issue":"3","key":"1639_CR43","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23031376","volume":"23","author":"CH Cheng","year":"2022","unstructured":"Cheng CH, Chen LR, Chen KH (2022) Osteoporosis due to hormone imbalance: an overview of the effects of estrogen deficiency and glucocorticoid overuse on bone turnover. Int J Mol Sci 23(3):1376","journal-title":"Int J Mol Sci"},{"key":"1639_CR44","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1016\/j.bone.2011.04.017","volume":"50","author":"M Ferron","year":"2012","unstructured":"Ferron M, McKee MD, Levine RL et al (2012) Intermittent injections of osteocalcin improve glucose metabolism and prevent type 2 diabetes in mice. Bone 50:568\u2013575","journal-title":"Bone"},{"key":"1639_CR45","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1007\/s12020-016-0926-5","volume":"53","author":"J Du","year":"2016","unstructured":"Du J, Zhang M, Lu J, Zhang X et al (2016) Osteocalcin improves nonalcoholic fatty liver disease in mice through activation of Nrf2 and inhibition of JNK. Endocrine 53:701\u2013709","journal-title":"Endocrine"},{"key":"1639_CR46","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1038\/s41401-019-0311-z","volume":"41","author":"X-L Zhang","year":"2020","unstructured":"Zhang X-L, Wang Y-N, Ma L-Y et al (2020) Uncarboxylated osteocalcin ameliorates hepatic glucose and lipid metabolism in KKAy mice via activating insulin signaling pathway. Acta Pharmacol Sin 41:383\u2013393","journal-title":"Acta Pharmacol Sin"},{"key":"1639_CR47","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.1111\/dom.14774","volume":"24","author":"ID Vachliotis","year":"2022","unstructured":"Vachliotis ID, Anastasilakis AD, Goulas A et al (2022) Nonalcoholic fatty liver disease and osteoporosis: a potential association with therapeutic implications. Diabetes Obes Metab 24:1702\u201320","journal-title":"Diabetes Obes Metab"},{"key":"1639_CR48","doi-asserted-by":"publisher","first-page":"299","DOI":"10.2174\/156652409787847191","volume":"9","author":"SA Polyzos","year":"2009","unstructured":"Polyzos SA, Kountouras J, Zavos C (2009) Nonalcoholic fatty liver disease: the pathogenetic roles of insulin resistance and adipocytokines. Curr Mol Med 9:299\u2013314","journal-title":"Curr Mol Med"},{"key":"1639_CR49","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/9178616","volume":"2021","author":"M Zhang","year":"2021","unstructured":"Zhang M, Nie X, Yuan Y et al (2021) Osteocalcin alleviates nonalcoholic fatty liver disease in mice through GPRC6A. Int J Endocrinol 2021:9178616","journal-title":"Int J Endocrinol"},{"key":"1639_CR50","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1002\/jbmr.4227","volume":"36","author":"M Xia","year":"2021","unstructured":"Xia M, Rong S, Zhu X et al (2021) Osteocalcin and non-alcoholic fatty liver disease: lessons from two population-based cohorts and animal models. J Bone Miner Res 36:712\u201328","journal-title":"J Bone Miner Res"},{"issue":"11","key":"1639_CR51","doi-asserted-by":"publisher","first-page":"3002","DOI":"10.1111\/jgh.15631","volume":"36","author":"V Potoupni","year":"2021","unstructured":"Duan Y, Pan X, Luo J, et al (2022) Association of inflammatory cytokines with non-alcoholic fatty liver disease. Front Immunol 13:880298","journal-title":"J Gastroenterol Hepatol"},{"issue":"6","key":"1639_CR52","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1136\/gutjnl-2017-313884","volume":"66","author":"LA Adams","year":"2017","unstructured":"Adams LA, Anstee QM, Tilg H et al (2017) Non-alcoholic fatty liver disease and its relationship with cardio-vascular disease and other extrahepatic diseases. Gut 66(6):1138\u20131153","journal-title":"Gut"},{"issue":"8","key":"1639_CR53","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1016\/j.metabol.2015.11.006","volume":"65","author":"SA Polyzos","year":"2016","unstructured":"Polyzos SA, Kountouras J, Mantzoros CS (2016) Adipokines in nonalcoholic fatty liver disease. Metabolism 65(8):1062\u20131079","journal-title":"Metabolism"},{"key":"1639_CR54","doi-asserted-by":"publisher","first-page":"99","DOI":"10.2147\/JIR.S203590","volume":"12","author":"FY Azizieh","year":"2019","unstructured":"Azzu V, Vacca M, Virtue S, et al (2020) Adipose tissue-liver cross talk in the control of whole-body metabolism: implications in nonalcoholic fatty liver disease. Gastroenterology 158(7):1899-1912","journal-title":"J Inflamm Res"},{"issue":"1","key":"1639_CR55","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1007\/s00774-020-01175-1","volume":"39","author":"H Yasuda","year":"2021","unstructured":"Yasuda H (2021) Discovery of the RANKL\/RANK\/OPG system. J Bone Miner Metab 39(1):2\u201311","journal-title":"J Bone Miner Metab"},{"key":"1639_CR56","doi-asserted-by":"crossref","unstructured":"Bu SY, Hunt TS, Smith BJ (2009) Dried plum polyphenols attenuate the detrimental effects of TNF-alpha on osteoblast function coincident with up-regulation of Runx2, Osterix and IGF-I. J Nutr Biochem 20(1):35-44","DOI":"10.1016\/j.jnutbio.2007.11.012"},{"issue":"1","key":"1639_CR57","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/s41413-024-00342-8","volume":"12","author":"L Hu","year":"2024","unstructured":"Hu L, Chen W, Qian A et al (2024) Wnt\/\u03b2-catenin signaling components and mechanisms in bone formation, homeostasis, and disease. Bone Res 12(1):39","journal-title":"Bone Res"},{"issue":"2","key":"1639_CR58","doi-asserted-by":"publisher","DOI":"10.3390\/antiox12020373","volume":"12","author":"G Marcucci","year":"2023","unstructured":"Marcucci G, Domazetovic V, Nediani C, Ruzzolini J, Favre C, Brandi ML (2023) Oxidative stress and natural antioxidants in osteoporosis: novel preventive and therapeutic approaches. Antioxidants 12(2):373","journal-title":"Antioxidants"},{"issue":"2","key":"1639_CR59","first-page":"92","volume":"42","author":"CS Mantzoros","year":"2017","unstructured":"Ru JY, Wang YF (2020) Osteocyte apoptosis: the roles and key molecular mechanisms in resorption-related bone diseases. Cell Death Dis 11(10):846","journal-title":"Minerva Endocrinol"},{"key":"1639_CR60","doi-asserted-by":"publisher","first-page":"197","DOI":"10.3109\/03008209609029192","volume":"35","author":"MD McKee","year":"1996","unstructured":"McKee MD, Nanci A (1996) Osteopontin: an interfacial extracellular matrix protein in mineralized tissues. Connect Tissue Res 35:197\u2013205","journal-title":"Connect Tissue Res"},{"issue":"4","key":"1639_CR61","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.aohep.2020.01.001","volume":"19","author":"R Bruha","year":"2020","unstructured":"Bruha R, Vitek L, Smid V (2020) Osteopontin - a potential biomarker of advanced liver disease. Ann Hepatol 19(4):344\u2013352","journal-title":"Ann Hepatol"},{"issue":"4","key":"1639_CR62","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1002\/hep.31582","volume":"73","author":"Z Song","year":"2021","unstructured":"Song Z, Chen W, Athavale D et al (2021) Osteopontin takes center stage in chronic liver disease. Hepatology 73(4):1594\u20131608","journal-title":"Hepatology"},{"key":"1639_CR63","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0236353","volume":"15","author":"M Kriss","year":"2020","unstructured":"Kriss M, Golden-Mason L, Kaplan J et al (2020) Increased hepatic and circulating chemokine and osteopontin expression occurs early in human NAFLD development. PLoS One 15:e0236353","journal-title":"PLoS One"},{"issue":"1","key":"1639_CR64","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1002\/hep.23998","volume":"53","author":"WK Syn","year":"2011","unstructured":"Syn WK, Choi SS, Liaskou E et al (2011) Osteopontin is induced by hedgehog pathway activation and promotes fibrosis progression in nonalcoholic steatohepatitis. Hepatology 53(1):106\u2013115","journal-title":"Hepatology"},{"key":"1639_CR65","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1002\/hep4.1237","volume":"2","author":"O Glass","year":"2018","unstructured":"Glass O, Henao R, Patel K et al (2018) Serum interleukin-8, osteopontin, and monocyte chemoattractant protein 1 are associated with hepatic fibrosis in patients with nonalcoholic fatty liver disease. Hepatol Commun 2:1344\u201355","journal-title":"Hepatol Commun"},{"key":"1639_CR66","doi-asserted-by":"publisher","first-page":"2568","DOI":"10.1002\/oby.23868","volume":"31","author":"F Soysouvanh","year":"2023","unstructured":"Patouraux S, Bonnafous S, Voican CS, et al (2012) The osteopontin level in liver, adipose tissue and serum is correlated with fibrosis in patients with alcoholic liver disease. PLoS One 7(4):e35612","journal-title":"Obesity"},{"key":"1639_CR67","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.dld.2012.08.017","volume":"45","author":"Y Yilmaz","year":"2013","unstructured":"Wen Y, Jeong S, Xia Q et al (2016) Role of osteopontin in liver diseases. Int J Biol Sci 12(9):1121-1128","journal-title":"Dig Liver Dis"},{"issue":"6","key":"1639_CR68","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2022.100482","volume":"4","author":"I Graupera","year":"2022","unstructured":"Syn WK, Agboola KM, Swiderska M, et al (2012) NKT-associated hedgehog and osteopontin drive fibrogenesis in non-alcoholic fatty liver disease. Gut 61(9):1323-1329","journal-title":"JHEP Rep"},{"issue":"8","key":"1639_CR69","doi-asserted-by":"publisher","DOI":"10.1111\/acel.13183","volume":"19","author":"B G\u00f3mez-Santos","year":"2020","unstructured":"Coombes JD, Swiderska-Syn M, Doll\u00e9 L, et al (2015) Osteopontin neutralisation abrogates the liver progenitor cell response and fibrogenesis in mice. Gut 64(7):1120-1131","journal-title":"Aging Cell"},{"key":"1639_CR70","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.molmet.2014.03.004","volume":"3","author":"F Kahles","year":"2014","unstructured":"Bai RJ, Li YS, Zhang FJ (2022) Osteopontin, a bridge links osteoarthritis and osteoporosis. Front Endocrinol (Lausanne) 13:1012508","journal-title":"Mol Metab"},{"key":"1639_CR71","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/s00223-001-1121-z","volume":"71","author":"AL Boskey","year":"2002","unstructured":"Boskey AL, Spevak L, Paschalis E et al (2002) Osteopontin deficiency increases mineral content and mineral crystallinity in mouse bone. Calcif Tissue Int 71:145\u2013154","journal-title":"Calcif Tissue Int"},{"issue":"14","key":"1639_CR72","doi-asserted-by":"publisher","first-page":"8156","DOI":"10.1073\/pnas.96.14.8156","volume":"96","author":"H Yoshitake","year":"1999","unstructured":"Yoshitake H, Rittling SR, Denhardt DT et al (1999) Osteopontin-deficient mice are resistant to ovariectomy- induced bone resorption. Proc Natl Acad Sci U S A 96(14):8156\u20138160","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"1639_CR73","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/j.bbrc.2014.08.149","volume":"452","author":"B Zhang","year":"2014","unstructured":"Franz\u00e9n A, Hultenby K, Reinholt FP, et al (2008) Altered osteoclast development and function in osteopontin deficient mice. J Orthop Res 26(5):721-728","journal-title":"Biochem Biophys Res Commun"},{"issue":"5","key":"1639_CR74","doi-asserted-by":"publisher","first-page":"728","DOI":"10.3945\/an.117.015545","volume":"8","author":"O Sadeghi","year":"2017","unstructured":"Sadeghi O, Saneei P, Nasiri M et al (2017) Abdominal obesity and risk of hip fracture: a systematic review and meta-analysis of prospective studies. Adv Nutr 8(5):728\u2013738","journal-title":"Adv Nutr"},{"issue":"5","key":"1639_CR75","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1007\/s00223-016-0229-0","volume":"100","author":"JS Walsh","year":"2017","unstructured":"Walsh JS, Vilaca T (2017) Obesity, type 2 diabetes and bone in adults. Calcif Tissue Int 100(5):528\u2013535","journal-title":"Calcif Tissue Int"},{"issue":"6","key":"1639_CR76","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1210\/jc.2016-3609","volume":"102","author":"C Verroken","year":"2017","unstructured":"Verroken C, Zmierczak HG, Goemaere S et al (2017) Insulin resistance is associated with smaller cortical bone size in nondiabetic men at the age of peak bone mass. J Clin Endocrinol Metab 102(6):1807\u20131815","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"1639_CR77","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1007\/s40520-019-01206-6","volume":"31","author":"G Mihai","year":"2019","unstructured":"Mihai G, Gasparik AI, Pascanu IM, Cevei M, Hutanu A, Pop RM (2019) The influence of visfatin, RBP-4 and insulin resistance on bone mineral density in women with treated primary osteoporosis. Aging Clin Exp Res 31(6):889\u2013895","journal-title":"Aging Clin Exp Res"},{"issue":"3","key":"1639_CR78","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1210\/jc.2013-3338","volume":"99","author":"D Shin","year":"2014","unstructured":"Shin D, Kim S, Kim KH et al (2014) Association between insulin resistance and bone mass in men. J Clin Endocrinol Metab 99(3):988\u2013995","journal-title":"J Clin Endocrinol Metab"},{"key":"1639_CR79","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1007\/s11657-013-0142-3","volume":"8","author":"YH Kim","year":"2013","unstructured":"Kim YH, Cho KH, Choi YS et al (2013) Low bone mineral density is associated with metabolic syndrome in South Korean men but not in women: the 2008\u20132010 Korean National Health and Nutrition Examination Survey. Arch Osteoporos 8:142","journal-title":"Arch Osteoporos"},{"issue":"2","key":"1639_CR80","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.jocd.2017.05.015","volume":"21","author":"R Cherif","year":"2018","unstructured":"Cherif R, Mahjoub F, Sahli H et al (2018) Positive association of obesity and insulin resistance with bone mineral density in Tunisian postmenopausal women. J Clin Densitom 21(2):163\u2013171","journal-title":"J Clin Densitom"},{"issue":"8","key":"1639_CR81","doi-asserted-by":"publisher","first-page":"3114","DOI":"10.1210\/jc.2016-1726","volume":"101","author":"VV Shanbhogue","year":"2016","unstructured":"Shanbhogue VV, Finkelstein JS, Bouxsein ML et al (2016) Association between insulin resistance and bone structure in nondiabetic postmenopausal women. J Clin Endocrinol Metab 101(8):3114\u20133122","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"1639_CR82","doi-asserted-by":"publisher","first-page":"542","DOI":"10.3390\/biom12040542","volume":"12","author":"M Khalid","year":"2022","unstructured":"Khalid M, Petroianu G, Adem A (2022) Advanced glycation end products and diabetes mellitus: mechanisms and perspectives. Biomolecules 12(4):542","journal-title":"Biomolecules"},{"issue":"1","key":"1639_CR83","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4196\/kjpp.2014.18.1.1","volume":"18","author":"VP Singh","year":"2014","unstructured":"Masenga SK, Kabwe LS, Chakulya M et al (2023) Mechanisms of oxidative stress in metabolic syndrome. Int J Mol Sci 24(9):7898","journal-title":"Korean J Physiol Pharmacol"},{"issue":"5","key":"1639_CR84","doi-asserted-by":"publisher","first-page":"e2271","DOI":"10.1210\/clinem\/dgab027","volume":"106","author":"P Sihota","year":"2021","unstructured":"Sihota P, Yadav RN, Dhaliwal R et al (2021) Investigation of mechanical, material, and compositional determinants of human trabecular bone quality in type 2 diabetes. J Clin Endocrinol Metab 106(5):e2271\u2013e2289","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"1639_CR85","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1002\/jbmr.3711","volume":"34","author":"HB Hunt","year":"2019","unstructured":"Hunt HB, Torres AM, Palomino PM et al (2019) Altered tissue composition, microarchitecture, and mechanical performance in cancellous bone from men with type 2 diabetes mellitus. J Bone Miner Res 34(7):1191\u20131206","journal-title":"J Bone Miner Res"},{"issue":"6","key":"1639_CR86","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1007\/s11914-016-0332-1","volume":"14","author":"M Yamamoto","year":"2016","unstructured":"Yamamoto M, Sugimoto T (2016) Advanced glycation end products, diabetes, and bone strength. Curr Osteoporos Rep 14(6):320\u2013326","journal-title":"Curr Osteoporos Rep"},{"key":"1639_CR87","doi-asserted-by":"publisher","first-page":"1104709","DOI":"10.3389\/fcell.2023.1104709","volume":"11","author":"LM Burkhardt","year":"2023","unstructured":"Burkhardt LM, Bucher CH, L\u00f6ffler J et al (2023) The benefits of adipocyte metabolism in bone health and regeneration. Front Cell Dev Biol 11:1104709","journal-title":"Front Cell Dev Biol"},{"issue":"1","key":"1639_CR88","doi-asserted-by":"publisher","first-page":"8090","DOI":"10.1038\/s41598-022-12273-7","volume":"12","author":"TY Tai","year":"2022","unstructured":"Pu Y, Wu H, Lu S, et al (2016) Adiponectin promotes human jaw bone marrow stem cell osteogenesis. J Dent Res 95(7):769-775","journal-title":"Sci Rep"},{"issue":"2","key":"1639_CR89","doi-asserted-by":"publisher","first-page":"52","DOI":"10.3390\/biomedicines6020052","volume":"6","author":"T Gamberi","year":"2018","unstructured":"Oshima K, Nampei A, Matsuda M, et al (2005) Adiponectin increases bone mass by suppressing osteoclast and activating osteoblast. Biochem Biophys Res Commun 331(2):520-526","journal-title":"Biomedicines"},{"issue":"5","key":"1639_CR90","first-page":"917","volume":"18","author":"K Alkhathami","year":"2023","unstructured":"Choi HM, Doss HM, Kim KS (2020) Multifaceted physiological roles of adiponectin in inflammation and diseases. Int J Mol Sci 21(4):1219","journal-title":"J Taibah Univ Med Sci"},{"key":"1639_CR91","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.990667","volume":"13","author":"W Wang","year":"2022","unstructured":"Liu C, Li X (2025) Role of leptin and adiponectin in immune response and inflammation. Int Immunopharmacol 161:115082","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"1639_CR92","doi-asserted-by":"publisher","first-page":"5807","DOI":"10.1038\/s41467-020-19668-y","volume":"11","author":"H Xu","year":"2020","unstructured":"Iwabu M, Yamauchi T, Okada-Iwabu M, et al (2010) Adiponectin and AdipoR1 regulate PGC-1alpha and mitochondria by Ca(2+) and AMPK\/SIRT1. Nature 464(7293):1313-1319","journal-title":"Nat Commun"},{"issue":"3","key":"1639_CR93","doi-asserted-by":"publisher","DOI":"10.1111\/eci.13403","volume":"51","author":"L Caserza","year":"2021","unstructured":"Lin YY, Chen CY, Chuang TY, et al (2014) Adiponectin receptor 1 regulates bone formation and osteoblast differentiation by GSK-3\u03b2\/\u03b2-catenin signaling in mice. Bone 64:147-154","journal-title":"Eur J Clin Invest"},{"issue":"3","key":"1639_CR94","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1039\/D0FO02664F","volume":"12","author":"J Qiao","year":"2021","unstructured":"Qiao J, Wu Y, Ren Y (2021) The impact of a high fat diet on bones: potential mechanisms. Food Funct 12(3):963\u2013975","journal-title":"Food Funct"},{"issue":"6","key":"1639_CR95","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.3390\/nu11061393","volume":"11","author":"H Hafner","year":"2019","unstructured":"Hafner H, Chang E, Carlson Z et al (2019) Lactational high-fat diet exposure programs metabolic inflammation and bone marrow adiposity in male offspring. Nutrients 11(6):1393","journal-title":"Nutrients"},{"key":"1639_CR96","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.jnutbio.2018.06.006","volume":"59","author":"CC Montalvany-Antonucci","year":"2018","unstructured":"Tencerova M, Figeac F, Ditzel N, et al (2018) High-fat diet-induced obesity promotes expansion of bone marrow adipose tissue and impairs skeletal stem cell functions in mice. J Bone Miner Res 33(6):1154-1165","journal-title":"J Nutr Biochem"},{"issue":"12","key":"1639_CR97","doi-asserted-by":"publisher","first-page":"4195","DOI":"10.3390\/nu13124195","volume":"13","author":"HC Spooner","year":"2021","unstructured":"Zhang L, Zheng YL, Wang R et al (2022) Exercise for osteoporosis: a literature review of pathology and mechanism. Front Immunol 13:1005665","journal-title":"Nutrients"},{"key":"1639_CR98","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.585689","volume":"11","author":"S Marini","year":"2020","unstructured":"Kostenuik PJ, Harris J, Halloran BP, et al (1999) Skeletal unloading causes resistance of osteoprogenitor cells to parathyroid hormone and to insulin-like growth factor-I. J Bone Miner Res 14(1):21-31","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1639_CR99","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1007\/978-981-15-1792-1_24","volume":"1228","author":"G Fiorentino","year":"2020","unstructured":"Sutor TW, Kura J, Mattingly AJ et al (2022) The effects of exercise and activity-based physical therapy on bone after spinal cord injury. Int J Mol Sci 23(2):608","journal-title":"Adv Exp Med Biol"},{"issue":"2","key":"1639_CR100","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.pbiomolbio.2015.11.005","volume":"122","author":"Y Yuan","year":"2016","unstructured":"Yuan Y, Chen X, Zhang L et al (2016) The roles of exercise in bone remodeling and in prevention and treatment of osteoporosis. Prog Biophys Mol Biol 122(2):122\u2013130","journal-title":"Prog Biophys Mol Biol"},{"issue":"2","key":"1639_CR101","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1210\/endrev\/bnad027","volume":"45","author":"PC Eng","year":"2024","unstructured":"Eng PC, Phylactou M, Qayum A et al (2024) Obesity-related hypogonadism in women. Endocr Rev 45(2):171\u2013189","journal-title":"Endocr Rev"},{"issue":"15","key":"1639_CR102","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23158194","volume":"23","author":"VA Genchi","year":"2022","unstructured":"Genchi VA, Rossi E, Lauriola C et al (2022) Adipose tissue dysfunction and obesity-related male hypogonadism. Int J Mol Sci 23(15):8194","journal-title":"Int J Mol Sci"},{"issue":"8","key":"1639_CR103","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1111\/obr.12863","volume":"20","author":"DF Carrageta","year":"2019","unstructured":"Carrageta DF, Oliveira PF, Alves MG, Monteiro MP (2019) Obesity and male hypogonadism: tales of a vicious cycle. Obes Rev 20(8):1148\u20131158","journal-title":"Obes Rev"},{"issue":"7","key":"1639_CR104","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1038\/s41443-021-00496-7","volume":"34","author":"M Louters","year":"2022","unstructured":"Louters M, Pearlman M, Solsrud E, Pearlman A (2022) Functional hypogonadism among patients with obesity, diabetes, and metabolic syndrome. Int J Impot Res 34(7):714\u2013720","journal-title":"Int J Impot Res"},{"issue":"4","key":"1639_CR105","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1111\/obr.12239","volume":"16","author":"M Pereira-Santos","year":"2015","unstructured":"Pereira-Santos M, Costa PR, Assis AM, Santos CA, Santos DB (2015) Obesity and vitamin D deficiency: a systematic review and meta-analysis. Obes Rev 16(4):341\u2013349","journal-title":"Obes Rev"},{"issue":"6","key":"1639_CR106","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1097\/MED.0000000000000371","volume":"24","author":"JS Walsh","year":"2017","unstructured":"Walsh JS, Bowles S, Evans AL (2017) Vitamin D in obesity. Curr Opin Endocrinol Diabetes Obes 24(6):389\u2013394","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"issue":"10","key":"1639_CR107","first-page":"17221","volume":"8","author":"X Wang","year":"2015","unstructured":"Wang X, Li W, Zhang Y et al (2015) Association between vitamin D and non-alcoholic fatty liver disease\/non-alcoholic steatohepatitis: results from a meta-analysis. Int J Clin Exp Med 8(10):17221\u201317234","journal-title":"Int J Clin Exp Med"},{"issue":"1","key":"1639_CR108","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1152\/physrev.00014.2015","volume":"96","author":"S Christakos","year":"2016","unstructured":"Christakos S, Dhawan P, Verstuyf A, Verlinden L, Carmeliet G (2016) Vitamin D: metabolism, molecular mechanism of action, and pleiotropic effects. Physiol Rev 96(1):365\u2013408","journal-title":"Physiol Rev"},{"issue":"3","key":"1639_CR109","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/j.ecl.2012.04.003","volume":"41","author":"T Yoshida","year":"2012","unstructured":"Yoshida T, Stern PH (2012) How vitamin D works on bone. Endocrinol Metab Clin North Am 41(3):557\u2013569","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"2","key":"1639_CR110","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1111\/apa.13685","volume":"106","author":"S Liang","year":"2017","unstructured":"Liang S, Cheng X, Hu Y et al (2017) Insulin-like growth factor 1 and metabolic parameters are associated with nonalcoholic fatty liver disease in obese children and adolescents. Acta Paediatr 106(2):298\u2013303","journal-title":"Acta Paediatr"},{"issue":"1","key":"1639_CR111","doi-asserted-by":"publisher","DOI":"10.1038\/ctg.2016.72","volume":"8","author":"LE Dichtel","year":"2017","unstructured":"Dichtel LE, Corey KE, Misdraji J et al (2017) The association between IGF-1 levels and the histologic severity of nonalcoholic fatty liver disease. Clin Transl Gastroenterol 8(1):e217","journal-title":"Clin Transl Gastroenterol"},{"issue":"2","key":"1639_CR112","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/s12020-019-01982-1","volume":"65","author":"Y Yao","year":"2019","unstructured":"Yao Y, Miao X, Zhu D et al (2019) Insulin-like growth factor-1 and non-alcoholic fatty liver disease: a systemic review and meta-analysis. Endocrine 65(2):227\u2013237","journal-title":"Endocrine"},{"issue":"46","key":"1639_CR113","doi-asserted-by":"publisher","first-page":"44005","DOI":"10.1074\/jbc.M208265200","volume":"277","author":"M Zhang","year":"2002","unstructured":"Zhang M, Xuan S, Bouxsein ML et al (2002) Osteoblast-specific knockout of the insulin-like growth factor (IGF) receptor gene reveals an essential role of IGF signaling in bone matrix mineralization. J Biol Chem 277(46):44005\u201344012","journal-title":"J Biol Chem"},{"issue":"9","key":"1639_CR114","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1359\/jbmr.060610","volume":"21","author":"Y Wang","year":"2006","unstructured":"Wang Y, Nishida S, Elalieh HZ, Long RK, Halloran BP, Bikle DD (2006) Role of IGF-I signaling in regulating osteoclastogenesis. J Bone Miner Res 21(9):1350\u20131358","journal-title":"J Bone Miner Res"},{"issue":"4","key":"1639_CR115","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1210\/er.2018-00005","volume":"39","author":"G Mazziotti","year":"2018","unstructured":"Mazziotti G, Frara S, Giustina A (2018) Pituitary diseases and bone. Endocr Rev 39(4):440\u2013488","journal-title":"Endocr Rev"},{"issue":"6","key":"1639_CR116","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1038\/s41574-022-00649-8","volume":"18","author":"G Mazziotti","year":"2022","unstructured":"Mazziotti G, Lania AG, Canalis E (2022) Skeletal disorders associated with the growth hormone - insulin-like growth factor 1 axis. Nat Rev Endocrinol 18(6):353\u2013365","journal-title":"Nat Rev Endocrinol"}],"container-title":["Archives of Osteoporosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11657-025-01639-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11657-025-01639-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11657-025-01639-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T10:46:59Z","timestamp":1768474019000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11657-025-01639-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,12]]},"references-count":116,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1639"],"URL":"https:\/\/doi.org\/10.1007\/s11657-025-01639-9","relation":{},"ISSN":["1862-3514"],"issn-type":[{"value":"1862-3514","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,12]]},"assertion":[{"value":"12 January 2026","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}],"article-number":"22"}}